West Pharmaceutical Services Announces Upcoming Conference Presentation
West Pharmaceutical Services, Inc. (NYSE: WST), a recognized leader in injectable drug administration solutions, is set to participate in a key industry event. The company will present at the J.P. Morgan Healthcare Conference scheduled on a Wednesday morning in January in San Francisco. This event offers a platform for communication between influential companies and investors.
Details of the Conference
The presentation is scheduled for 9:00 AM PST. Attendees can catch the live webcast via the Investors section of West's corporate website. This accessibility reflects West’s commitment to transparency and engagement with stakeholders looking to understand more about its operations and future prospects.
Live Webcast and Replay Availability
Following the live presentation, a replay will be made available on the company’s website for about 90 days. This allows those unable to attend the live event a chance to review the discussions and insights shared during the conference.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. prides itself on being a premier supplier of innovative and reliable injectable solutions and related services. The organization collaborates closely with both seasoned and emerging drug developers to ensure that essential medicines are effectively contained and delivered to patients safely. This dedication to quality and innovation has positioned West as a vital player in the field.
Global Presence and Manufacturing Capability
The company operates from its headquarters in Exton, Pennsylvania, and boasts a workforce of over 10,000 dedicated employees across 50 locations, including 25 advanced manufacturing facilities worldwide. Each year, West delivers an impressive 41 billion components and devices, ensuring timely and safe medication delivery to healthcare providers and patients alike.
Financial Performance
In its most recent fiscal year, West Pharmaceutical Services achieved remarkable financial growth, generating nearly $2.89 billion in net sales. This performance highlights their successful strategies and the trust placed in them by clients across the globe. As a publicly traded entity on the New York Stock Exchange (NYSE: WST), it also maintains a position on the esteemed Standard & Poor's 500 index, underscoring its influence within the market.
Conclusion
West Pharmaceutical Services continues to lead the way in providing high-quality solutions for injectable drug delivery. Their participation in conferences like the J.P. Morgan Healthcare Conference underscores their commitment to innovation and partnership in the healthcare industry. Stakeholders and the public can look forward to engaging insights and updates from West Pharmaceuticals as it maintains its trajectory of growth and excellence in service delivery.
Frequently Asked Questions
1. What is the purpose of West's participation in the conference?
West participates to share insights about its innovations and strengthen connections with investors and industry peers.
2. When will West present at the conference?
West will present on a Wednesday morning in January at the J.P. Morgan Healthcare Conference.
3. How can I access the live webcast of the presentation?
The live webcast will be accessible through the Investors section of West's company website.
4. What financial achievements has West recently disclosed?
In its latest fiscal year, West achieved $2.89 billion in net sales.
5. Where is West Pharmaceutical Services headquartered?
West Pharmaceutical Services is headquartered in Exton, Pennsylvania.
